Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Xiu-Wen Liao"'
Autor:
Yu‐Hung Wang, Feng‐Ming Tien, Cheng‐Hong Tsai, Huai‐Hsuan Huang, Jia‐Hau Liu, Xiu‐Wen Liao, Jih‐Luh Tang, Ming Yao, Bor‐Sheng Ko
Publikováno v:
Cancer Reports, Vol 5, Iss 3, Pp n/a-n/a (2022)
Abstract Background Allogeneic stem cell transplantation (allo‐HSCT) is the ultimate cure for acute lymphoblastic leukemia (ALL). Aim This study was performed to compare the outcomes of ALL patients receiving busulfan (Bu) with cyclophosphamide (Cy
Externí odkaz:
https://doaj.org/article/7c73caafb79c4ebfa2b45d8ac3d92733
Autor:
Wen-Chien Chou, Sheng-Chuan Huang, Ming-Chih Liu, Xiu-Wen Liao, Yuan-Yeh Kuo, Mei-Hsuan Tseng, Jia-Hau Liu, Shang-Ju Wu, Hwei-Fang Tien, Chien-Yuan Chen, Hsin-An Hou, Liang-In Lin, Yen-Ling Peng, Szu-Chun Hsu, Bor-Sheng Ko, Ming Yao, Yi-Kuang Chuang, Feng-Ming Tien, Jih-Luh Tang, Chiawen Liu, Mei-Fang Hou, Yu-Sin Wu, Cheng-Hong Tsai
Publikováno v:
Bone Marrow Transplantation. 57:95-105
The mutant burden of FLT3-ITD modulates its prognostic impact on patients with acute myeloid leukemia (AML). However, for patients with low allelic ratio (AR) FLT3-ITD (FLT3-ITDlow, AR
Autor:
Feng-Ming Tien, Xiu-Wen Liao, Jih-Luh Tang, Ming Yao, Huai-Hsuan Huang, Cheng-Hong Tsai, Jia-Hau Liu, Bor-Sheng Ko, Yu-Hung Wang
Publikováno v:
Cancer reports (Hoboken, N.J.). 5(3)
Background Allogeneic stem cell transplantation (allo-HSCT) is the ultimate cure for acute lymphoblastic leukemia (ALL). Aim This study was performed to compare the outcomes of ALL patients receiving busulfan (Bu) with cyclophosphamide (Cy)-based or
Autor:
Wen-Chien Chou, Chien-Hung Chen, Jih-Luh Tang, Yao-Chang Chen, Ming Yao, Chien-Ting Lin, Cheng-Hong Tsai, Hsin-An Hou, Jia-Hau Liu, Hwei-Fang Tien, Shang-Ju Wu, Bor-Sheng Ko, Shang-Yi Huang, Chi-Cheng Li, Xiu-Wen Liao
Publikováno v:
British Journal of Haematology. 186:72-85
Reactivation of hepatitis B virus (HBV) by reverse seroconversion (HBV-RS) after allogeneic haematopoietic stem cell transplantation (allo-HSCT) can occur in patients with resolved HBV infection (rHBV, defined as negative HBV surface antigen [HBsAg]
Autor:
Hsin-An Hou, Shang-Ju Wu, Shang-Yi Huang, Feng-Ming Tien, Xiu-Wen Liao, Ming Yao, Yuan-Yeh Kuo, Cheng-Hong Tsai, Chia-Wen Liu, Mei-Hsuan Tseng, Yu-Chiao Chiu, Wen-Chien Chou, Chien-Ting Lin, Hwei-Fang Tien, Chien-Yuan Chen, Ming-Chih Liu, Yen-Ling Peng, Liang-In Lin, Szu-Chun Hsu, Bor-Sheng Ko, Jih-Luh Tang
Publikováno v:
Blood Cancer Journal, Vol 8, Iss 9, Pp 1-13 (2018)
Blood Cancer Journal
Blood Cancer Journal
Mutations of the GATA binding protein 2 (GATA2) gene in myeloid malignancies usually cluster in the zinc finger 1 (ZF1) and the ZF2 domains. Mutations in different locations of GATA2 may have distinct impact on clinico-biological features and outcome
Autor:
Xiu-Wen Liao, Mei-Hsuan Tseng, Yuan-Yeh Kuo, Ming Yao, Chia-Wen Liu, Yen-Ling Peng, Ming-Chih Liu, Hwei-Fang Tien, Cheng-Hong Tsai, Chieh-Yu Liu, Chien-Chin Lin, Wen-Chien Chou, Jih-Luh Tang, Hsin-An Hou, Liang-In Lin
Publikováno v:
Blood Cancer Journal
Blood Cancer Journal, Vol 8, Iss 4, Pp 1-13 (2018)
Blood Cancer Journal, Vol 8, Iss 4, Pp 1-13 (2018)
Gene mutations have not yet been included in the 2016 WHO classification and revised International Prognostic Scoring System (IPSS-R), which are now widely utilized to discriminate myelodysplastic syndrome (MDS) patients regarding risk of leukemia ev
Autor:
Yu-Hsuan Chen, Jia Hau Liu, Yung-Li Yang, Ming Chih Liu, Kai-Hsin Lin, Shang Ju Wu, Xiu Wen Liao, Bor-Sheng Ko, Ming Yao, Chi Cheng Li, Shang-Yi Huang, Meng Yu Lu, Chieh Yu Liu, Sung-Hsin Kuo, Jih-Luh Tang, Wen-Chien Chou, Chien-Ting Lin, Chien-Yuan Chen, Hsien Tang Chou, Hwei-Fang Tien, Cheng-Hong Tsai, Chieh-Lung Cheng, Hsiu-Hao Chang, Yao-Chang Chen, Yun Chiang, Szu Chun Hsu, Hsin-An Hou, Woei Tsay, Chien-Chin Lin, Sheng-Chieh Chou, Jian Kuen Wu, Dong-Tsamn Lin
Publikováno v:
Scientific Reports
Allogeneic hematopoietic stem cell transplantation is a curative-intent treatment for patients with high-risk hematologic diseases. However, interstitial pneumonitis (IP) and other toxicities remain major concerns after total body irradiation (TBI).
Publikováno v:
Biology of Blood and Marrow Transplantation. 25:S188
The allogeneic hematopoietic stem-cell transplantation (allo-HSCT) is viewed as the ultimate cure for acute lymphoblastic leukemia (ALL). An essential component of allo-HSCT is the conditioning regimen administered before the hematopoietic stem-cell
Publikováno v:
Therapeutic Radiology and Oncology. 2:29-29
Background: Central nervous system (CNS) involvement is a poor prognostic factor for patients with acute leukemia. Currently, there is still no standard approach to effectively reduce the CNS relapse rate and improve outcome. The purpose of the study